Syntr Health Technologies

Year Founded

2016

Ownership

Private

Employees

~10

Therapeutic Areas

OtherOncologyDermatology

Stage

Commercial

Modalities

Medical devicesAutologous cell therapy

Syntr Health Technologies General Information

FDA-cleared SyntrFuge System for processing autologous adipose tissue, with initial sales to VA hospitals and plastic surgery practices

Contact Information

Website

Primary Industry

[ "Biotech", "Medical Devices" ]

Corporate Office

Irvine, California
United States

Drug Pipeline

No pipeline data available

For full access to Syntr Health Technologies's pipeline data

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Syntr Health Technologies Funding

No funding data available

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

To view Syntr Health Technologies's complete valuation and funding history, request access »

Syntr Health Technologies Investors

MassChallenge (accelerator/investor)

Investor Type: Venture Capital

Holding: Minority